Understanding and Communicating the Benefits and Risks of Denosumab, Raloxifene, and Teriparatide for the Treatment of Osteoporosis

✍ Scribed by Lewiecki, E. Michael; Miller, Paul D.; Harris, Steve T.; Bauer, Douglas C.; Davison, K. Shawn; Dian, Larry; Hanley, David A.; McClung, Michael R.; Yuen, Chui K.; Kendler, David L.

• Book ID: 125448403
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 187 KB
• Volume: 17
• Category: Article
• ISSN: 1094-6950
• DOI: 10.1016/j.jocd.2013.09.018